Annual FCF
$5.05 B
-$8.88 B-63.75%
31 December 2023
Summary:
BioNTech SE annual free cash flow is currently $5.05 billion, with the most recent change of -$8.88 billion (-63.75%) on 31 December 2023. During the last 3 years, it has risen by +$5.16 billion (+4572.33%). BNTX annual FCF is now -63.75% below its all-time high of $13.94 billion, reached on 31 December 2022.BNTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$770.16 M
-$2.37 B-148.01%
01 September 2024
Summary:
BioNTech SE quarterly free cash flow is currently -$770.16 million, with the most recent change of -$2.37 billion (-148.01%) on 01 September 2024. Over the past year, it has dropped by -$1.48 billion (-208.01%). BNTX quarterly FCF is now -117.20% below its all-time high of $4.48 billion, reached on 31 March 2022.BNTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$1.03 B
-$1.48 B-58.99%
01 September 2024
Summary:
BioNTech SE TTM free cash flow is currently $1.03 billion, with the most recent change of -$1.48 billion (-58.99%) on 01 September 2024. Over the past year, it has dropped by -$4.64 billion (-81.83%). BNTX TTM FCF is now -92.60% below its all-time high of $13.94 billion, reached on 31 December 2022.BNTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.8% | -208.0% | -81.8% |
| 3 y3 years | +4572.3% | -144.4% | -27.0% |
| 5 y5 years | +3494.2% | -900.9% | +572.1% |
BNTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -63.8% | +4572.3% | -117.2% | +2.1% | -92.6% | +18.5% |
| 5 y | 5 years | -63.8% | +1773.7% | -117.2% | +2.1% | -92.6% | +279.4% |
| alltime | all time | -63.8% | +1773.7% | -117.2% | +2.1% | -92.6% | +279.4% |
BioNTech SE Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$770.16 M(-148.0%) | $1.03 B(-59.0%) |
| June 2024 | - | $1.60 B(-425.2%) | $2.51 B(-53.0%) |
| Mar 2024 | - | -$493.35 M(-171.4%) | $5.34 B(+5.8%) |
| Dec 2023 | $5.05 B(-63.8%) | $690.54 M(-3.2%) | $5.05 B(-11.0%) |
| Sept 2023 | - | $713.08 M(-83.9%) | $5.67 B(-38.6%) |
| June 2023 | - | $4.43 B(-663.8%) | $9.24 B(+6.5%) |
| Mar 2023 | - | -$786.41 M(-159.9%) | $8.67 B(-37.8%) |
| Dec 2022 | $13.94 B(+1500.9%) | $1.31 B(-69.3%) | $13.94 B(+13.1%) |
| Sept 2022 | - | $4.28 B(+10.6%) | $12.33 B(+26.0%) |
| June 2022 | - | $3.87 B(-13.6%) | $9.78 B(+69.9%) |
| Mar 2022 | - | $4.48 B(-1616.7%) | $5.76 B(+561.4%) |
| Dec 2021 | $870.47 M | -$295.15 M(-117.0%) | $870.47 M(-38.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $1.73 B(-1202.4%) | $1.41 B(-345.9%) |
| June 2021 | - | -$157.21 M(-61.7%) | -$574.96 M(+26.7%) |
| Mar 2021 | - | -$410.31 M(-265.5%) | -$453.62 M(+301.6%) |
| Dec 2020 | -$112.95 M(-62.6%) | $247.93 M(-197.1%) | -$112.95 M(-74.6%) |
| Sept 2020 | - | -$255.37 M(+611.9%) | -$444.24 M(+67.1%) |
| June 2020 | - | -$35.87 M(-48.5%) | -$265.82 M(-10.7%) |
| Mar 2020 | - | -$69.63 M(-16.5%) | -$297.70 M(-1.4%) |
| Dec 2019 | -$301.82 M(+102.8%) | -$83.36 M(+8.3%) | -$301.82 M(+38.2%) |
| Sept 2019 | - | -$76.95 M(+13.6%) | -$218.46 M(+54.4%) |
| June 2019 | - | -$67.76 M(-8.1%) | -$141.51 M(+91.9%) |
| Mar 2019 | - | -$73.75 M | -$73.75 M |
| Dec 2018 | -$148.82 M(+19.1%) | - | - |
| Dec 2017 | -$124.92 M | - | - |
FAQ
- What is BioNTech SE annual free cash flow?
- What is the all time high annual FCF for BioNTech SE?
- What is BioNTech SE annual FCF year-on-year change?
- What is BioNTech SE quarterly free cash flow?
- What is the all time high quarterly FCF for BioNTech SE?
- What is BioNTech SE quarterly FCF year-on-year change?
- What is BioNTech SE TTM free cash flow?
- What is the all time high TTM FCF for BioNTech SE?
- What is BioNTech SE TTM FCF year-on-year change?
What is BioNTech SE annual free cash flow?
The current annual FCF of BNTX is $5.05 B
What is the all time high annual FCF for BioNTech SE?
BioNTech SE all-time high annual free cash flow is $13.94 B
What is BioNTech SE annual FCF year-on-year change?
Over the past year, BNTX annual free cash flow has changed by -$8.88 B (-63.75%)
What is BioNTech SE quarterly free cash flow?
The current quarterly FCF of BNTX is -$770.16 M
What is the all time high quarterly FCF for BioNTech SE?
BioNTech SE all-time high quarterly free cash flow is $4.48 B
What is BioNTech SE quarterly FCF year-on-year change?
Over the past year, BNTX quarterly free cash flow has changed by -$1.48 B (-208.01%)
What is BioNTech SE TTM free cash flow?
The current TTM FCF of BNTX is $1.03 B
What is the all time high TTM FCF for BioNTech SE?
BioNTech SE all-time high TTM free cash flow is $13.94 B
What is BioNTech SE TTM FCF year-on-year change?
Over the past year, BNTX TTM free cash flow has changed by -$4.64 B (-81.83%)